Michael Helwig Selected Research

Biomarkers (Surrogate Marker)

1/2016

The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Helwig Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2016 - 01/2013
3	Synucleinopathies 01/2017 - 03/2015
2	Disease Progression 03/2015 - 07/2013
2	Body Weight (Weight, Body) 05/2012 - 09/2006
1	Proteostasis Deficiencies 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 02/2014
1	Amyloidosis 01/2013
1	Infections 12/2011

Drug/Important Bio-Agent (IBA)

7	SynucleinsIBA 01/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 02/2014 - 01/2013
2	Peptides (Polypeptides)IBA 02/2014 - 01/2013
2	LeptinIBA 05/2012 - 09/2006
1	alpha-SynucleinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2013
1	Neuroendocrine Secretory Protein 7B2IBA 01/2013
1	Glucagon (Glukagon)FDA Link 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2011
1	Insulin (Novolin)FDA Link 09/2006